NASDAQ:GTBP | Cash Flow Statement | GT Biopharma, Inc.

Complete source-backed cash-flow history.

Available history
2010-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.52M
2026-03-31-$2.83M-$2.47M$4.58M
2025-12-31-$5.71M-$4.02M$144,000.00$8.31M
2025-09-30-$3.11M
2025-06-30-$30.17M
2025-03-31-$776,000.00-$2.2M$616,000.00
2024-12-31-$3.78M-$2.47M$1,000.00$0.00
2024-09-30-$3.41M
2024-06-30-$3.71M
2024-03-31-$2.27M-$4.16M$5.03M
2023-12-31-$2.96M-$2.05M$478,000.00$0.00
2023-09-30-$2.42M
2023-06-30-$1.99M
2023-03-31-$227,000.00-$2.91M-$6.99M$6.27M
2022-12-31-$5.58M-$4.3M$7.51M-$1,000.00
2022-09-30-$6.88M
2022-06-30-$2.98M
2022-03-31-$5.44M-$5.22M$3.53M
2021-12-31-$18.02M-$3.71M$2.99M$0.00
2021-09-30-$5.45M
2021-06-30-$4.86M
2021-03-31-$29.68M-$3.68M$25.94M
2020-12-31-$6.29M-$1.93M$0.00$6.87M
2020-09-30-$2.88M
2020-06-30-$17.42M
2020-03-31-$1.71M-$223,000.00$200,000.00
2019-12-31-$1.47M-$485,000.00$0.00$0.00$200,000.00
2019-09-30-$29.88M
2019-06-30-$2.79M
2019-03-31-$4.51M-$961,000.00$0.00$0.00$952,000.00
2018-12-31-$4.23M-$1.24M$32,000.00-$32,000.00$104,000.00
2018-09-30-$235.78M
2018-06-30-$9.08M
2018-03-31-$10.09M-$4.23M$2,000.00-$2,000.00$6.52M
2017-12-31-$6.03M-$2.15M$4,000.00-$4,000.00$0.00
2017-09-30-$130.63M
2017-06-30-$2.46M
2017-03-31-$5.06M-$650,000.00$0.00$0.00$866,000.00
2016-12-31-$14.09M-$135,000.00$0.00
2016-09-30-$3.63M
2016-06-30$1.54M
2016-03-31$25.95M-$167,000.00$150,000.00
2015-12-31-$37.38M-$944,000.00$950,000.00
2015-09-30-$1.69M
2015-06-30$26.86M
2015-03-31-$20.52M-$1.79M$2.35M
2014-12-31-$18.64M-$1.04M$1.25M
2014-09-30-$4.22M
2014-06-30-$262,000.00
2014-03-31-$371,000.00-$90,000.00$50,000.00
2013-12-31-$354,000.00-$369,000.00$424,000.00
2013-09-30-$319,000.00
2013-06-30-$319,000.00
2013-03-31$468,000.00-$138,000.00$1,000.00
2012-12-31-$761,000.00-$214,000.00$315,000.00
2012-09-30-$1.4M
2012-06-30-$2.4M
2012-03-31-$615,000.00-$192,000.00$220,000.00
2011-12-31-$1.14M-$324,000.00$416,000.00
2011-09-30$23,000.00
2011-03-31-$1.92M-$147,000.00$94,000.00
2010-12-31-$662,000.00-$377,000.00$250,000.00
2010-09-30-$633,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$28.35M-$12.91M$229,000.00$15.78M
2024-12-31-$13.16M-$12.9M$12.89M$2.98M
2023-12-31-$7.6M-$8.85M-$2.01M$6.27M
2022-12-31-$20.88M-$15.22M$12.15M-$224,000.00
2021-12-31-$58.01M-$15.61M-$23.04M$42.32M
2020-12-31-$28.3M-$7.26M$0.00$12.53M
2019-12-31-$38.65M-$3.66M$0.00$200,000.00$3.43M
2018-12-31-$259.19M-$10.68M$36,000.00-$36,000.00$10.2M
2017-12-31-$144.17M-$5.43M$4,000.00-$4,000.00$5.99M
2016-12-31$9.77M-$1.93M$0.00$0.00$1.9M
2015-12-31-$32.73M-$4.66M$1,000.00-$1,000.00$3.85M
2014-12-31-$23.49M-$1.75M$6,000.00-$6,000.00$2.58M
2013-12-31-$501,000.00-$442,000.00$0.00$0.00$425,000.00
2012-12-31-$5.17M-$987,000.00$2,000.00-$2,000.00$930,000.00
2011-12-31-$3.7M-$963,000.00$0.00$0.00$1M
2010-12-31-$3M-$1.54M$296,000.00